Recently the news has come on the internet that Dorf Ketal Chemicals India Pvt.Ltd had appeared as the front-runner for thing chemical markers Aquapharm Chemicals Pvt. Ltd, two individuals aware of the matter stated. Dorf Ketal is the primer international chemical, manufacturing and supply firm specializing in the treatment of chance crude oil. Since the news came on the internet it went viral on many social media platforms. Now lots of people are super curious to know the complete information about the news. We have more information about the news and will share it with you in this article.
Dorf Ketal has been planning to sell a five-year, non-convertible debenture at 8.5-9% stake to increase 3,800 crores for the transaction, one of the two individuals mentioned above said on the condition of obscurity. Aquapharm’s landlords have been looking to increase 4,000 crore- 4,400 crore from the stake sale, the two people said. Others in the fight for the Pune-based firm include Tata Chemicals Ltd and RP-Sanjiv Goenka Group company PCBL Ltd. Aquapharm’s proprietors had hired a US-based investment bank to explore a full stake sale on April 2023. Scroll down to the next page for more information about the news.
As per the report, Dorf-Ketal Group has hit numerous acquisitions in recent globally, and has sales of more than $1 billion, the second person declared. It started on 6 January when a subsidiary received Canada’s Fluid Energy Group’s international limited and synthetic acid business, which had a turnover of 480 crore. Last year in October, Dorf Ketal acquired Clariant’s North American land oil business. In April it reached India-based Khyati Chemicals. Healthy cash accrual and moderate capital expenditure plans have supported Dorf-Ketal’s financial risk shape after FY23, a Crisil, You are on the right page for more information about the news, so please read the complete article.
Meanwhile “While total debt may increase to 1,350 crore by 31 March 2023, the pace may slow to ~1x due to increasing in debt to finance recent acquisitions. The group intends to focus on integrating and growing the acquired businesses over the next 1-2 years. Tata Chemicals decreased to comment, spokesperson for Aquapharm Chemicals, the RP-Sanjiv Goenka group and Dorf-Ketal did not reply to emailed requests for comment. The Mangwani family, led by V.K Mangwani, owns around 50% of Aquapharm. Here we have shared all the information that we had if we get any information then we will update you soon. Stay tuned to us for more updates.